Ian Lawrence Turner
CIK: 0002121622
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RADX
Radiopharm Theranostics Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Turner Ian Lawrence
Turner Ian Lawrence (SEC CIK 0002121622) files insider reports with the SEC as Director of Radiopharm Theranostics Ltd (RADX).
Signal8 holds 1 ownership filing by Turner Ian Lawrence, a Form 3, filed on Apr 1, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Turner Ian Lawrence's filings is in CARLTON SOUTH, VICTORIA.
Other insiders filing for Radiopharm Theranostics Ltd (RADX)
- Voliotis Dimitris, Chief Medical Officer
- HOPPER PAUL, Director
- Donnelly Noel, Director
- Goodwin Bruce Michael, Director